UPDATED: After Supreme Court rejection, Teva mulls options in GSK 'skinny label' feud
Fierce Pharma
MAY 15, 2023
UPDATED: After Supreme Court rejection, Teva mulls options in GSK 'skinny label' feud fkansteiner Mon, 05/15/2023 - 10:59
Fierce Pharma
MAY 15, 2023
UPDATED: After Supreme Court rejection, Teva mulls options in GSK 'skinny label' feud fkansteiner Mon, 05/15/2023 - 10:59
MedCity News
MAY 15, 2023
Patient demand for digital payment communication — both reminders about bills, as well as text messages that enable bill payment — is on the rise, according to a recent report. This is in line with growing consumerism trends in the U.S. — patients want their healthcare payment experience to mimic the convenience and ease they have when they pay for things like travel or retail goods.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MAY 15, 2023
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
MedCity News
MAY 15, 2023
By selling partial royalties to approved hemophilia gene therapy Hemgenix, uniQure gains immediate cash to support its pipeline, including a Huntington’s disease gene therapy already in the clinic. The royalty deal extends uniQure’s cash runway into 2026.
Fierce Pharma
MAY 15, 2023
Dermavant's Vtama hits the mark in another phase 3 eczema trial kdunleavy Mon, 05/15/2023 - 19:54
MedCity News
MAY 15, 2023
On the surface, it sounds like one of the simplest procedures undertaken at a health system: answering the phone. But anyone who works at a health system knows it is not that simple.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MAY 15, 2023
Nido Biosciences’ lead drug hits a previously undrugged pocket as a way to potentially treat the rare neuromuscular disorder spinal and bulbar muscular atrophy. The startup’s tech platform screens neurons to find targets for new neurological disorder drugs.
Fierce Pharma
MAY 15, 2023
After Hemgenix approvals, uniQure cashes out some of its royalty rights for $375M-plus zbecker Mon, 05/15/2023 - 10:58
PM360
MAY 15, 2023
Maya Angelou said, “If you’re going to live, leave a legacy. Make a mark on the world that can’t be erased.” For nine years, we have looked to recognize those people in healthcare and life sciences who are making a mark on our industry, on patients, on colleagues, on the world. These people represent our ELITE 100: the individuals and teams who throughout their careers are building legacies marked by helping people live better—and hopefully longer—lives.
Fierce Pharma
MAY 15, 2023
With NICE nod, Gilead clears another regulatory hurdle in Europe for Hepcludex kdunleavy Mon, 05/15/2023 - 09:30
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
MAY 15, 2023
When we bring physicians from underserved communities into research through a reimagined model, we can impact better health outcomes rooted in quality data that allows us to thrive from more diversity and better representation while providing patients with greater access to new care options.
Fierce Pharma
MAY 15, 2023
Novartis brings on 8 business vets for Sandoz's new board, including 4 women kdunleavy Mon, 05/15/2023 - 11:19
PharmaTech
MAY 15, 2023
Forge will provide adeno-associated virus (AAV) process development, toxicology, cGMP manufacturing, and analytical services to Life Bio, which will occur at Forge’s gene therapy facility in Columbus, Ohio called the Hearth.
Pharmaceutical Technology
MAY 15, 2023
The US Food and Drug Administration (FDA) has approved Astellas Pharma’s Veozah (fezolinetant) for use against moderate to severe vasomotor symptoms caused by menopause on May 12 after some delays due to an extended review. This marks the first-ever FDA approval of a nonhormonal neurokinin 3 (NK3) receptor antagonist for use against vasomotor symptoms caused by menopause.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
MAY 15, 2023
Through an expanded partnership with Teladoc, HealthJoy is providing access to virtual primary care services for the first time. The company already offers employers services for areas including mental health, nutrition and musculoskeletal therapy.
PM360
MAY 15, 2023
Laura Blair SVP, Business Development ConnectiveRx The Relationship Builder Raised by Italian immigrant parents who expected her to become an accountant, Laura Blair began her career as an accountant in the finance department of a pharmaceutical company. After a developmental day of shadowing a pharma sales rep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010.
Pharmaceutical Technology
MAY 15, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Small molecules in Pharmaceuticals: Quinoline derivat
Copyright Clearance Center
MAY 15, 2023
The post Swimming in the AI Data Lake: Why Disclosure and Versions of Record Are More Important than Ever appeared first on Copyright Clearance Center.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
MedCity News
MAY 15, 2023
One in four providers said that health technology vendors haven’t kept their promises in the past year. KLAS Research debunked four common misconceptions vendors may have about why so many providers feel this way — such as the false notion that employees who weren’t part of the purchasing decision feel the most disappointed by vendors or the misbelief that it’s better to not make promises in the first place.
PM360
MAY 15, 2023
As healthcare champions, we embrace the power of patient education. It can enhance health literacy, promote self-efficacy, encourage adherence, and optimize health outcomes. Education is empowering and transformative— when patients read it. If patients read it. This can be disheartening for those of us dedicated to writing and designing impactful and engaging patient education.
MedCity News
MAY 15, 2023
Amino Health’s $80 million in financing was led by Transformation Capital and Oxford Finance. With the funding, the company hopes to reach and engage more members and grow its partnerships with employers and third party administrators.
MedReps
MAY 15, 2023
Do you suffer from interview anxiety? If so, you aren’t alone. Most people get nervous before interviews and even start panicking about them the night before. It’s the combination of not knowing what to expect when you get there and the “please hire me” vibes that tend to amp up the anxiety. Unfortunately, being anxious during an interview can lead to not answering questions completely, blanking on tasks you’ve done and details you want to tell the hiring manager and remaining somewhat fidgety d
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
PharmaTimes
MAY 15, 2023
NICE’s decision will result in eligible patients using a treatment that slows or halts aspects of the illness
Pharmaceutical Technology
MAY 15, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Nucleoside chemical sy
PharmaTimes
MAY 15, 2023
The company intends to advance AF drugs that address current risk concerns with existing therapies
Copyright Clearance Center
MAY 15, 2023
The post Info Pros in a Data-Driven Enterprise appeared first on Copyright Clearance Center.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
PM360
MAY 15, 2023
Karina Castagna SVP Access and Adherence OptimizeRx Advancing Digital Access at Point-of-Care Karina Castagna believes every life sciences company must have digital omnichannel as a key pillar in its marketing and access strategy for point of care (POC) and point of prescribe to better serve both providers and patients. Ultimately, she helps industry utilize technology that connects the ecosystem from the manufacturer, pharmacy, hub, and payer to bring therapies to patients.
Pharma Marketing Network
MAY 15, 2023
Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered.
PM360
MAY 15, 2023
Don Abramo Executive Director, Leniolisib Marketing Pharming Healthcare Inc. A Truly Rare Marketer Activated PI3K delta syndrome (APDS) is a recently discovered rare disease that really puts the rare in rare. Classified as a rare disease back in 2013, it’s estimated only one to two people per million suffer from it around the globe. Furthermore, the first genetic test for it only became available in 2017, which is the only way to definitively diagnose APDS.
Referral MD
MAY 15, 2023
As a healthcare provider, building a patient base can be a challenge. One way to increase your patient base is through referrals. Referral coordinators are an essential part of this process, as they connect potential patients with healthcare providers. Here are a few tips for making it easier for referral coordinators to work with you: 1. Make it easy to refer patients To make it easy for referral coordinators to send patients your way, ensure your contact information is readily available.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Let's personalize your content